Evidence map›Paper›PMID 23315198›Full record

ArticleJournal of molecular modeling2013

Interactions of selected indole derivatives with phospholipase A₂: in silico and in vitro analysis.

Kalarickal Vijayan Dileep, Chandran Remya, Ignatius Tintu, Madathilkovilakathu Haridas, Chittalakkottu Sadasivan

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular modeling, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kalarickal Vijayan DileepDepartment of Biotechnology and Microbiology and Inter-University Centre for Bioscience, Kannur University, Thalassery Campus, Kannur, Palayad 670661, India.
Chandran Remya
Ignatius Tintu
Madathilkovilakathu Haridas
Chittalakkottu Sadasivan
Kannur University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phospholipase A2 (PLA₂) is one of the key enzymes involved in the formation of inflammatory mediators. Inhibition of PLA₂ is considered to be one of the efficient methods to control inflammation. In silico docking studies of 160 selected indole derivatives performed against porcine pancreatic PLA₂ (ppsPLA2) suggested that, CID2324681, CID8617 (indolebutyric acid or IBA), CID22097771 and CID802 (indoleacetic acid or IAA) exhibited highest binding energies. In silico analysis was carried out to predict some of the ADME properties. The binding potential of these compounds with human non pancreatic secretory PLA₂ (hnpsPLA₂) was determined using molecular docking studies. In order to corroborate the in silico results, enzyme kinetics and isothermal titration calorimetric analysis of the two selected compounds, IAA and IBA were performed against ppsPLA₂. From the analysis, it was concluded that IAA and IBA can act as competitive inhibitors to the enzyme and may be used as anti inflammatory agents.

Indexed as

AnimalsAnti-Inflammatory AgentsBinding SitesEnzyme InhibitorsHumansIndoleacetic AcidsIndolesIsoenzymesKineticsMolecular Docking SimulationPancreasPhospholipase A2 InhibitorsPhospholipases A2Protein BindingSwineThermodynamicsAnti-Inflammatory AgentsEnzyme Inhibitorsindoleacetic acidIndoleacetic Acidsindolebutyric acidIndolesIsoenzymesPhospholipase A2 InhibitorsPhospholipases A2

Identifiers

PMID23315198
OpenAlexW1977326452

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.